Results 281 to 290 of about 82,598 (315)
Some of the next articles are maybe not open access.
Otolaryngologic Clinics of North America, 2011
Sublingual immunotherapy (SLIT) has been shown to be safe and efficacious in treating allergic rhinitis. It has been used in Europe for more than 20 years, and interest in the United States is increasing. SLIT has been shown to elicit immunologic changes similar to subcutaneous injection immunotherapy.
Sandra Y, Lin, Bryan, Leatherman
openaire +2 more sources
Sublingual immunotherapy (SLIT) has been shown to be safe and efficacious in treating allergic rhinitis. It has been used in Europe for more than 20 years, and interest in the United States is increasing. SLIT has been shown to elicit immunologic changes similar to subcutaneous injection immunotherapy.
Sandra Y, Lin, Bryan, Leatherman
openaire +2 more sources
Journal of Allergy and Clinical Immunology, 2001
Recent claims have been made that sublingual immunotherapy (SLIT) may be a viable alternative to injection immunotherapy (SIT). Animal studies show that when allergens are administered topically, they are handled differently, and IgE responses can be reduced.
Frew, Anthony J., Smith, Helen E.
openaire +3 more sources
Recent claims have been made that sublingual immunotherapy (SLIT) may be a viable alternative to injection immunotherapy (SIT). Animal studies show that when allergens are administered topically, they are handled differently, and IgE responses can be reduced.
Frew, Anthony J., Smith, Helen E.
openaire +3 more sources
Annals of Otology, Rhinology & Laryngology, 1991
The smallest of the major salivary glands, the sublingual gland is unusually the origin of a salivary neoplasm. When it is, however, the odds are greatly in favor of the neoplasm's being malignant. The gland is also uniquely associated with two nonneoplastic disorders: The cervical ranula and herniation through the mylohyoid muscle
openaire +2 more sources
The smallest of the major salivary glands, the sublingual gland is unusually the origin of a salivary neoplasm. When it is, however, the odds are greatly in favor of the neoplasm's being malignant. The gland is also uniquely associated with two nonneoplastic disorders: The cervical ranula and herniation through the mylohyoid muscle
openaire +2 more sources
Oral Surgery, Oral Medicine, Oral Pathology, 1975
Abstract A large sublingual dermoid cyst was excised from the oral cavity of a 56-year-old man who had had the lesion for 15 years. A brief review of the development and histology of these unusual lesions is given.
R C, Chakravorty, P F, Schatzki
openaire +2 more sources
Abstract A large sublingual dermoid cyst was excised from the oral cavity of a 56-year-old man who had had the lesion for 15 years. A brief review of the development and histology of these unusual lesions is given.
R C, Chakravorty, P F, Schatzki
openaire +2 more sources
The Journal of Dermatology, 1998
AbstractForegut cysts are usually found in the mediastinum, the lung, or the wall of the upper gastrointestinal tract, but only rarely at the base of tongue. We report a sublingual foregut cyst in a 27‐year‐old man.
Y S, Kim, S K, Ahn, S H, Lee
openaire +2 more sources
AbstractForegut cysts are usually found in the mediastinum, the lung, or the wall of the upper gastrointestinal tract, but only rarely at the base of tongue. We report a sublingual foregut cyst in a 27‐year‐old man.
Y S, Kim, S K, Ahn, S H, Lee
openaire +2 more sources
Journal of Craniofacial Surgery, 2002
Dermoid and epidermoid cysts are developmental pathologies that occur in the head and neck with an incidence ranging from 1.6 to 6.9%, and they represent less than 0.01% of all oral cavity cysts. Our purpose is to report a case of sublingual epidermoid cyst of the floor of the mouth.
Francesco Saverio, De Ponte +3 more
openaire +2 more sources
Dermoid and epidermoid cysts are developmental pathologies that occur in the head and neck with an incidence ranging from 1.6 to 6.9%, and they represent less than 0.01% of all oral cavity cysts. Our purpose is to report a case of sublingual epidermoid cyst of the floor of the mouth.
Francesco Saverio, De Ponte +3 more
openaire +2 more sources
Critical Reviews in Therapeutic Drug Carrier Systems, 2008
The sublingual route is one of the early modes of administration for systemic drug delivery. This route avoids first-pass metabolism and affords quick drug entry into the systemic circulation. Attempts have been made to deliver various pharmacologically active agents, such as cardiovascular drugs, analgesics, and peptides, across the sublingual mucosa.
Goswami, Tarun +2 more
openaire +3 more sources
The sublingual route is one of the early modes of administration for systemic drug delivery. This route avoids first-pass metabolism and affords quick drug entry into the systemic circulation. Attempts have been made to deliver various pharmacologically active agents, such as cardiovascular drugs, analgesics, and peptides, across the sublingual mucosa.
Goswami, Tarun +2 more
openaire +3 more sources
2011
Schwannomalar, periferik, kranial ve otonomik sinir kılıflarındaki schwann hücrelerinden kaynaklanan benign tümörlerdir. Schwann hücresi içeren sinir liflerinin bulunduğu her yerde görülebilmekle beraber, %25-45 kadarı baş-boyun bölgesinde görülür. İntraoral yerleşimleri daha nadirdir.
YÖRÜK, Özgür +4 more
openaire +2 more sources
Schwannomalar, periferik, kranial ve otonomik sinir kılıflarındaki schwann hücrelerinden kaynaklanan benign tümörlerdir. Schwann hücresi içeren sinir liflerinin bulunduğu her yerde görülebilmekle beraber, %25-45 kadarı baş-boyun bölgesinde görülür. İntraoral yerleşimleri daha nadirdir.
YÖRÜK, Özgür +4 more
openaire +2 more sources
Current Opinion in Allergy & Clinical Immunology, 2013
It is likely that approval of allergen preparations for sublingual immunotherapy (SLIT) will soon occur in the United States. This article reviews experience with SLIT in this country, concentrating on the large, multicenter trials that will provide the evidence of safety and efficacy necessary to obtain that approval.Large multicenter trials have been
openaire +2 more sources
It is likely that approval of allergen preparations for sublingual immunotherapy (SLIT) will soon occur in the United States. This article reviews experience with SLIT in this country, concentrating on the large, multicenter trials that will provide the evidence of safety and efficacy necessary to obtain that approval.Large multicenter trials have been
openaire +2 more sources
Sublingual specific immunotherapy.
Discovery medicine, 2010Sublingual application of allergen extracts in specific immunotherapy is a modern approach aimed at improving patient treatment acceptance through reduced serious side effects. This therapeutic approach has proven to be efficacious and safe for the treatment of allergies caused by airborne allergens: 1) studies have shown a rapid onset of action, as ...
Mösges R., El Hassan E., Passali D.
openaire +2 more sources